HIV / AIDS in the News

Once-Weekly HIV Pill Meets Phase 3 Endpoints, Advancing Potential First Long-Acting Oral Treatment - Contagion Live

 

Once-Weekly HIV Pill Meets Phase 3 Endpoints, Advancing Potential First Long-Acting Oral Treatment - Contagion Live

 

Bangor homeless camp closure disrupted response to HIV outbreak, CDC says - Bangor Daily News

 

Gilead and Merck’s once-weekly HIV pill meets trial goals - Investing.com

 

Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment - Business Wire

 

A Clinical Trial to Evaluate an Investigational Medicine for HIV-1 Preexposure Prophylaxis (PrEP) - Black Doctor

 

Structural strains threatening HIV care in Latino communities: Voices from front-line leaders - IDSA

 

Can the new UN political declaration get the HIV response back on track? - Devex

 

Activists mark 45 years since the start of the AIDS crisis with rally against Trump's health cuts - Advocate.com

 

Northern Lights Fun Run to support Thomas Judd Care Center’s HIV services - 9and10News.com

 

Study explains why HIV sometimes persists in blood post-treatment - Johns Hopkins University

 

South Africa HIV Prevention - The Herald Journal

 

South Africa HIV Prevention - The Herald Journal

 

South Africa HIV Prevention - The Herald Journal

 

South Africa HIV Prevention - The Herald Journal

 

South Africa HIV Prevention - The Herald Journal

 

Why a Detectable HIV Test Result Can Mean the Virus Is Already Broken - ScienceBlog.com

 

Could Flu Drugs Help Protect Memory in HIV? - Technology Networks

 

HIV enters the brain and doesn’t leave – paradoxically, drugs intended to reduce brain inflammation increase virus levels - Yahoo

 

How Macon’s HIV care went from one doctor’s fight to the pharmacy counter - Georgia Public Broadcasting

 

Scalable and sustainable primary HIV prevention models for people from key populations - ReliefWeb

 

5′ Leader Defects Fuel Persistent HIV-1 Viremia - Bioengineer.org

 

How a Former Goalkeeper Is Closing South Africa’s HIV Treatment Gap for Men - Angels in Medicine

 

Most cases of HIV persistence in blood following treatment explained by defective copies of the virus - EurekAlert!

 

South Africa rolls out new preventive HIV shot in 'major turning point' - France 24

 

Defective HIV copies explain most persistent traces in blood following treatment, study finds - Medical Xpress

 

A hard-fought win for HIV advocacy in the South comes after sudden cuts to costly meds - WUSF

 

BBC Future – Blueprint of a cure: The rare people who are invulnerable to HIV - Ragon Institute

 

Worse HIV control at diagnosis doesn't mean worse lymphoma outcomes - Aidsmap

 

PH secures 15K doses of injectable PrEP amid rising HIV infection - Philippine News Agency